Effect of adding betaxolol to dipivefrin therapy

Robert N. Weinreb, Robert Ritch, F. Harold Kushner

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


We evaluated the safety and effectiveness of adding topically administered betaxolol 0.5% twice daily in 39 patients with ocular hypertension or primary open-angle glaucoma already being treated with dipivefrin 0.1% twice daily. The addition of the betaxolol significantly decreased (P < .01) the mean intraocular pressure after two weeks (2.82 mm Hg) and four weeks (3.63 mm Hg). There were no significant changes in pulse rate, mean arterial pressure, or pupil diameter. The administration of betaxolol to patients already receiving dipivefrin appears to be clinically useful.

Original languageEnglish
Pages (from-to)196-198
Number of pages3
JournalAmerican Journal of Ophthalmology
Issue number2
StatePublished - 15 Feb 1986
Externally publishedYes


Dive into the research topics of 'Effect of adding betaxolol to dipivefrin therapy'. Together they form a unique fingerprint.

Cite this